SARS–CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis

Keyphrases

• Clinical Outcomes 9%
• Confidence Interval 27%
• COVID-19 100%
• COVID-19 Outcomes 100%
• COVID-19 Severity 9%
• Critical Appraisal Tool 9%
• Disease Risk 9%
• Hospitalization 18%
• Increased Mortality 9%
• Intensive Care Unit Admission 18%
• Joanna Briggs Institute 9%
• Literature Review Analysis 100%
• Low Risk 9%
• Mantel-Haenszel 9%
• Mechanical Ventilation 18%
• Meta-analysis 100%
• Methodologic Quality 9%
• Mortality Rate 18%
• Musculoskeletal Disorders 90%
• Newcastle-Ottawa Scale 9%
• Odds Ratio 18%
• Oxygen Supplementation 9%
• Random Effects Model 9%
• Relative Risk 9%
• Rheumatic Diseases 100%
• Risk of Bias 9%
• Risk Ratio 18%
• Risk-adjusted 9%
• Small number of Studies 9%
• Systematic Literature Review 100%

Nursing and Health Professions

• Artificial Respiration 18%
• Clinical Outcome 9%
• Confidence Interval 27%
• Critical Appraisal 9%
• Disease Severity 9%
• Infection 100%
• Intensive Care Unit 18%
• Meta Analysis 100%
• Mortality Rate 18%
• Musculoskeletal Disease 90%
• Newcastle-Ottawa Scale 9%
• Odds Ratio 18%
• Population 9%
• Prevalence 9%
• Rheumatic Disease 100%
• Supplementation 9%
• Systematic Review 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease Severity 9%
• Infection 100%
• Mortality Rate 18%
• Musculoskeletal Disease 90%
• Observational Study 9%
• Prevalence 9%
• Random Effects Model 9%
• Rheumatic Disease 100%